Spencer Sterling Prete

Spencer Prete practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.

Spencer Prete's NPI, 1750735171, was assigned on April 21, 2016. Spencer Prete holds Ohio license 35.137037.

Spencer Prete's primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.

Spencer Prete's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Spencer Prete practices. Vendor and product names are available with a free account.

Emergency medicine is Spencer Prete's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Spencer Prete is licensed in Ohio.

CMS data shows 255 Medicare services from Spencer Prete across 4 procedure codes in 2024, for 197 Medicare patients. Medicare paid $24,086 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 197 Medicare patients who saw Spencer Prete in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Spencer Prete's median patient age at 57, with 55% women.

In 2024, Spencer Prete wrote 159 Medicare Part D claims for 106 patients. 94% of them were for generic drugs. CMS names the drug for 53 of them, across 3 drugs with 11 or more claims each, at $152 in total drug cost. In 2023, CMS named 53 claims across 4 drugs.

Spencer Prete accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Spencer Prete from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $14.